Semaglutide has emerged as a novel treatment for type 2 diabetes. This manufactured glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and reducing glucagon https://andrewkyvm745769.blog2freedom.com/35725639/understanding-semaglutide-a-comprehensive-guide